The Latest Cardiac and Vascular News
By combining AI-guided echocardiograms and Virtual-First cardiology care, the new partnership enables early disease identification and management for patients from the comfort of their homes BRISBANE, Calif. and NEW YORK, July 28, 2022 /PRNewswire/ — Caption Health, the leader in providing services and AI to improve heart ultrasound access, and Heartbeat Health, the nation’s largest Virtual […]
~ 2Q22 sales and profit consistent with expectations ~ ~ Increasing 2022 sales and operating income outlook ~ PLANO, Texas, July 28, 2022 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for the three months ended July 1, 2022. Second Quarter 2022 Highlights (compared […]
WAYNE, Pa., July 28, 2022 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable September 15, 2022, to shareholders of record at the close of business on […]
Phase 2b RE-THINC ESRD study of fesomersen met its primary endpoint in patients with end-stage renal disease on hemodialysis Fesomersen demonstrated substantial and statistically significant reductions in Factor XI activity levels Fesomersen, a novel Factor XI antisense inhibitor designed to prevent thrombosis, was safe and well-tolerated in the study with up to […]
Tustin, California, July 27, 2022 (GLOBE NEWSWIRE) — Canon Medical Systems USA Inc., a commercial subsidiary of Canon Medical Systems Corporation and a global leader in innovative diagnostic imaging technology, today announces the completion of the acquisition of NXC Imaging, a medical imaging equipment distributor and service provider headquartered in Minneapolis, […]
THE WOODLANDS, Texas, July 28, 2022 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) (“Lexicon”) today announced the pricing of its previously announced underwritten public offering of 16,843,600 shares of its common stock, par value $0.001 (the “Common Stock”). The shares of Common Stock are being offered at a public […]
More Effective SofPulse® Results Compared With Bioelectronics RecoveryRx® Los Angeles, CA, July 28, 2022 (GLOBE NEWSWIRE) — Endonovo Therapeutics Inc. (OTCQB:ENDV) today released superior comparative results for its SofPulse® medical device for post-operative pain relief compared with Bioelectronics Corporation’s RecoveryRx®. The medical treatment comparisons were clinically evaluated based on three clinical trials for RecoveryRx® and […]
Q2 2022 reported revenue of $295.0 million, up 5.2% compared to Q2 2021 Q2 2022 constant currency revenue, organic* up 7.4% compared to Q2 2021 Q2 2022 GAAP operating margin of 7.9%, compared to 3.2% in Q2 2021 Q2 2022 non-GAAP operating margin of 19.1%, compared to 16.3% in Q2 […]
Annual Awards Program Recognizes State-of-the-Art Cardiac Technologies SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology for heart attack detection, was selected as winner of the annual Cardiovascular Innovations (CVI) 2022 Innovation Summit and Shark Tank Competition held on July […]
— BROOKLYN evaluates obicetrapib as an adjunct to diet and maximally tolerated lipid lowering therapy in patients requiring additional lowering of low-density lipoprotein cholesterol (LDL-C) — — Company expects to report initial data in 2024 — — With BROOKLYN underway, both pivotal trials designed to support a potential LDL-lowering approval […]
